The older we get the more cholesterol, calcium and other minerals get deposited along the walls of our blood vessels and obstruct them in the course of time. This process, which affects all of us, is called atherosclerosis. Ignoring it may have dangerous consequences as a sufficient oxygen supply of the organs is no longer guaranteed.
Induration and obstruction of the vessels through atherosclerosis affects not only individual sections but the body as a whole. When the coronary vessels are obstructed with plaques (this is the name of these deposits), then also the vessels in the brain, the kidneys, the lungs and all other organs are affected to a similar extent.
What also makes atherosclerosis so dangerous is the fact that it is a «silent» disease which damages the body as a whole and is often only discovered when damage has already been done. Thanks to the chelate therapy with Chelatin®, atherosclerosis can both be treated and also largely prevented.
As has been shown in many studies, the EDTA chelate therapy may successfully remove plaques from the walls of vessels and significantly improve or even normalize the blood flow – often also in far progressed cases. Removal of the plaques allows the blood, which carries oxygen and nutrients, to reach and fill up the body cells. In this way, the optimal function is restored.
The chemical structure of EDTA (ethylenediaminetetraacetic acid) is that of a weak acid which, together with metal ions, forms so-called chelates, particularly stable complexes of metals with organic compounds. In World War II, already, workers who worked in battery factories or with lead-containing paints and developed symptoms of lead poisoning were given EDTA.
Through the formation of chelate the poisonous lead was removed from the body (through the kidney). But much more surprising was that the therapy resulted in a significant improvement of the symptoms of many workers having cardiovascular diseases.
The mechanism of chelate formation is not yet fully understood and the processes involved are very complex. Simplified one can say that EDTA removes undesired calcium and other minerals conducive to the formation of plaques and eliminates them through the kidney.
Chelate therapy with EDTA has often been compared to a milling machine eating its way through blocked pipes and making them free again. However, this comparison is only partly correct. Milling machines would remove the atherosclerotic plaques but would not be kind to healthy tissue either. A better comparison would be that to a liquid decalcifyer: by repeated administration the deposits are simply dissolved. In the same way also harmful toxins are removed from the body.
Atherosclerosis: oral chelate therapy is primarily suited as a prophylaxis for complications caused by atherosclerosis – high blood pressure, concentration disturbances, peripheral occlusive vascular disease and impotence due to circulatory disturbances. EDTA is the insurance policy for the vessels as it slows the accumulation of plaques, and this may clearly delay the ageing of the cardiovascular system. Even younger people profit from this since the formation of plaques sets in very early and continues inexorably. Furthermore, EDTA improves the function of all organs in whose vessels atherosclerotic plaques are present. The symptoms of many degenerative diseases can be alleviated in this way and the ageing process clearly slowed. An increased blood circulation in the brain also increases the ability to concentrate.
EDTA removes toxins from the blood. Studies have shown that, due to environmental pollution, we store more and more toxic heavy metals as we grow older. The accumulation of these toxins increases the risk of vascular diseases.
It could also be shown that one simply feels better the smaller the quantities of heavy metal in the body are. For more than 50 years, EDTA has not only been the remedy of choice to treat acute lead poisoning, but also for mercury, aluminum and cadmium intoxications.
EDTA prevents the formation of blood clots since it binds to calcium, and calcium is necessary for blood coagulation. Inhibiting blood coagulation may prevent strokes, pulmonary embolisms, cardiac infarctions, venous thromboses and varicose veins – also the best-known drug worldwide, aspirin, acts according to the same principle.
EDTA strengthens the bones and lowers the cholesterol level by improving the calcium and cholesterol metabolisms. If the calcium levels are lowered by EDTA, a hormone of the parathyroid gland is activated (parathormone) which replenishes the calcium stores and builds them into the right place, namely into the bone. This prevents osteoporosis.
EDTA has a firming effect on the skin. One side effect that has been repeatedly found after intravenous administration was that the small wrinkles of the skin that come with age became fewer.
in pharmaceutical grade. Other ingredients: microcrystalline cellulose, dicalcium phosphate, tricalcium phosphate, SiO2.
In normal cases take 1 capsule 3 times a day at mealtimes with plenty of fluid.
EDTA is a safe, non-toxic substance. LD50 (a pharmacological value which shows at which dosage 50 percent of the laboratory animals or bacteria are killed) is at 2000 mg / kg body weight – which makes EDTA about 3.5 times less toxic than aspirin.
The most frequent but mostly not very pronounced side effects are nausea, dizziness and headache. The risk is highest when an infusion is given too fast or the dose is too big. The oral administration has practically no side effects.
EDTA has lowering effects on the blood sugar level and therefore also a positive effect on diabetes mellitus. The normal blood sugar level may drop during intake also in healthy persons, which may lead to tiredness, hunger and a feeling of dizziness. Taking the substance at mealtimes may avoid these reactions.
It should not be administered to children as administration to children has not yet been sufficiently researched.
EDTA can either be given intravenously or orally. The effect of intravenous administration is faster and stronger as 100 percent of the dose get into the blood circulation. Indications for an intravenous therapy are acute heavy-metal poisoning and severe atherosclerosis.
If administered orally, only about 15 percent of the dose get into the blood circulation. However, if EDTA is taken every day, similar effects as those with intravenous administration can be reached. The general rule is that after 5 to 6 weeks the same benefit is derived as with a one-time infusion. Oral intake is suited for persons for whom an acute treatment is not yet necessary. After intravenous administration, oral intake may also serve to maintain the effect.
It is self-understood that the therapy should be conducted only under the supervision and instruction of a specialist. Self-medication should be absolutely avoided. Store in a cool, dry place and keep out of reach of children.